Current state and future directions of autologous hematopoietic stem cell transplantation in systemic lupus erythematosus

Annals of the Rheumatic Diseases

Volumn 70, Issue 12, 2011, Pages 2071-2074

  Illei, Gabor G ^a   Cervera, Ricard ^b,c   Burt, Richard K ^d   Doria, Andrea ^b,e   Hiepe, Falk ^b,f   Jayne, David ^b,g   Pavletic, Steven ^h,i   Martin, Thierry ^b,j   Marmont, Alberto ^b,k   Saccardi, Riccardo ^b,l   Voskuyl, Alexandre E ^b,m   Farge, Dominique ^b,n  

^a NATIONAL INSTITUTE OF DENTAL AND CRANIOFACIAL RESEARCH   (United States)

^b European Bone Marrow Transplant Association   (Spain)

^c HOSPITAL CLÍNIC   (Spain)

^d NORTHWESTERN UNIVERSITY   (United States)

^e UNIVERSITY OF PADOVA   (Italy)

^f CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^g ADDENBROOKE S HOSPITAL   (United Kingdom)

^h NATIONAL CANCER INSTITUTE   (United States)

ⁱ Center for International Blood and Marrow Research   (United States)

^j UNIVERSITY HOSPITAL OF STRASBOURG   (France)

^k UNIVERSITY OF GENOA   (Italy)

^l CAREGGI UNIVERSITY HOSPITAL   (Italy)

^m VU UNIVERSITY MEDICAL CENTER   (Netherlands)

ⁿ SAINT LOUIS HOSPITAL   (France)

more..

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOSUPPRESSIVE AGENT;

AUTOLOGOUS BONE MARROW TRANSPLANTATION; AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; CLINICAL RESEARCH; DISEASE COURSE; DISEASE FREE SURVIVAL; DISEASE SEVERITY; EUROPE; FOLLOW UP; HUMAN; IMMUNE SYSTEM; IMMUNOSUPPRESSIVE TREATMENT; LONG TERM CARE; MAINTENANCE THERAPY; MEDICAL EXPERT; MEDICAL SOCIETY; MORTALITY; PATIENT SELECTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REMISSION; REVIEW; SYSTEMIC LUPUS ERYTHEMATOSUS; TREATMENT RESPONSE;

BIOMEDICAL RESEARCH; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; REMISSION INDUCTION; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 82755160832     PISSN: 00034967     EISSN: 14682060     Source Type: Journal    
DOI: 10.1136/ard.2010.148049     Document Type: Review

References (32)

1. Ippolito A, Petri M. An update on mortality in systemic lupus erythematosus. Clin Exp Rheumatol 2008;26(5 Suppl 51):S72-9.
2. Rus V, Hochberg MC. The epidemiology of systemic lupus erythematosus. In : Wallace DJ, Hahn BH, eds. Dubois' Lupus Erythematosus. Sixth edition. Philadelphia, PA:Lippincott Williams & Wilkins 2002:65-86.
3. Gladman DD, Hochberg MC. Epidemiology of systemic lupus erythematosus. In : Lahita RG, ed. Systemic Lupus Eythematosus. Third edition. San Diego: Academic Press 1999:537-50.
4. Nossent J, Cikes N, Kiss E, et al. Current causes of death in systemic lupus erythematosus in Europe, 2000-2004: relation to disease activity and damage accrual. Lupus 2007;16:309-17. (Pubitemid 47074831)
5. Bernatsky S, Boivin JF, Joseph L, et al. Mortality in systemic lupus erythematosus. Arthritis Rheum 2006;54:2550-7. (Pubitemid 44205016)
6. Cervera R, Khamashta MA, Font J, et al. Morbidity and mortality in systemic lupus erythematosus during a 5-year period. A multicenter prospective study of 1,000 patients. European Working Party on Systemic Lupus Erythematosus. Medicine (Baltimore) 1999;78:167-75. (Pubitemid 29231143)
7. Cervera R, Khamashta MA, Font J, et al. Morbidity and mortality in systemic lupus erythematosus during a 10-year period: a comparison of early and late manifestations in a cohort of 1,000 patients. Medicine (Baltimore) 2003;82:299-308. (Pubitemid 37229465)
8. Cervera R, Khamashta MA, Hughes GR. The Euro-lupus project: epidemiology of systemic lupus erythematosus in Europe. Lupus 2009;18:869-74.
9. Doria A, I accarino L, Ghirardello A, et al. Long-term prognosis and causes of death in systemic lupus erythematosus. Am J Med 2006;119:700-6.
10. To CH, Mok CC, Tang SS, et al. Prognostically distinct clinical patterns of systemic lupus erythematosus identified by cluster analysis. Lupus 2009;18:1267-75.
11. Illei GG, Austin HA, Crane M, et al. Combination therapy with pulse cyclophosphamide plus pulse methylprednisolone improves long-term renal outcome without adding toxicity in patients with lupus nephritis. Ann Intern Med 2001;135:248-57. (Pubitemid 32799338)
12. Marmont AM. Immune ablation with stem-cell rescue: a possible cure for systemic lupus erythematosus? Lupus 1993;2:151-6. (Pubitemid 23225630)
13. Ikehara S, Good RA, Nakamura T, et al. Rationale for bone marrow transplantation in the treatment of autoimmune diseases. Proc Natl Acad Sci USA 1985;82:2483-7. (Pubitemid 15071293)
14. Meloni G, Capria S, Vignetti M, et al. Blast crisis of chronic myelogenous leukemia in long-lasting systemic lupus erythematosus: regression of both diseases after autologous bone marrow transplantation. Blood 1997;89:4659. (Pubitemid 27260279)
15. Schachna L, Ryan PF, Schwarer AP. Malignancy-associated remission of systemic lupus erythematosus maintained by autologous peripheral blood stem cell transplantation. Arthritis Rheum 1998;41:2271-2. (Pubitemid 29009388)
16. Snowden JA, Patton WN, O'Donnell JL, et al. Prolonged remission of longstanding systemic lupus erythematosus after autologous bone marrow transplant for non-Hodgkin's lymphoma. Bone Marrow Transplant 1997;19:1247-50. (Pubitemid 27302736)
17. Marmont AM. Immune ablation followed by allogeneic or autologous bone marrow transplantation: a new treatment for severe autoimmune diseases? Stem Cells 1994;12:125-35. (Pubitemid 24045796)
18. Tyndall A, Gratwohl A. Blood and marrow stem cell transplants in autoimmune disease. A consensus report written on behalf of the European League Against Rheumatism (EULAR) and the European Group for Blood and Marrow Transplantation (EBMT). Br J Rheumatol 1997;36:390-2.
19. Jayne D, Passweg J, Marmont A, et al. Autologous stem cell transplantation for systemic lupus erythematosus. Lupus 2004;13:168-76. (Pubitemid 38478643)
20. Burt RK, Traynor A, Statkute L, et al. Nonmyeloablative hematopoietic stem cell transplantation for systemic lupus erythematosus. JAMA 2006;295:527-35. (Pubitemid 43200347)
21. Traynor AE, Corbridge TC, Eagan AE, et al. Prevalence and reversibility of pulmonary dysfunction in refractory systemic lupus: improvement correlates with disease remission following hematopoietic stem cell transplantation. Chest 2005;127:1680-9. (Pubitemid 46218795)
22. Statkute L, Traynor A, Oyama Y, et al. Antiphospholipid syndrome in patients with systemic lupus erythematosus treated by autologous hematopoietic stem cell transplantation. Blood 2005;106:2700-9. (Pubitemid 41510743)
23. Alexander T, Thiel A, Rosen O, et al. Depletion of autoreactive immunologic memory followed by autologous hematopoietic stem cell transplantation in patients with refractory SLE induces long-term remission through de novo generation of a juvenile and tolerant immune system. Blood 2009;113:214-23.
24. Illei GG, Nikolov NN, Hakim FT, et al. Long-term outcome of autologous hematopoietic stem cell transplantation (Auto HSCT) using lymphoablative conditioning regimen in systemic lupus erythematosus-the NIH experience. Bone Marrow Transplant 2010;45:S6.
25. Farge D, Labopin M, Tyndall A, et al. Autologous hematopoietic stem cell transplantation for autoimmune diseases: an observational study on 12 years'experience from the European Group for Blood and Marrow Transplantation Working Party on Autoimmune Diseases. Haematologica 2010;95:284-92.
26. Traynor AE, Schroeder J, Rosa RM, et al. Treatment of severe systemic lupus erythematosus with high-dose chemotherapy and haemopoietic stem-cell transplantation: a phase I study. Lancet 2000;356:701-7. (Pubitemid 30663238)
27. Zhang L, Bertucci AM, Ramsey-Goldman R, et al. Regulatory T cell (Treg) subsets return in patients with refractory lupus following stem cell transplantation, and TGF-beta-producing CD8+ Treg cells are associated with immunological remission of lupus. J Immunol 2009;183:6346-58.
28. Cervera R, Jayne D, Marmont AM, et al. Haematopoietic stem cell transplantation for severe autoimmune diseases Bone Marrow Transplant 2010;45:S1-S25.
29. Zhao X, Fu Y, Peng X. Autologous hematopoetic stem cell transplantation in the treatment of systemic lupus erythematosus. Bone Marrow Transplant 2002;29:S15.
30. Kim JA, Hong SY, Yoon JA, et al. Autologous stem cell transplantation using G-CSF primed bone marrow in severe refractory systemic lupus eythematosus. Bone Marrow Transplant 2005;35:S232.
31. Lisukov IA, Sizikova SA, Kulagin AD, et al. High-dose immunosuppression with autologous stem cell transplantation in severe refractory systemic lupus erythematosus. Lupus 2004;13:89-94. (Pubitemid 38222352)
32. Gualandi F, Bruno B, Van Lint MT, et al. Autologous stem cell transplantation for severe autoimmune diseases: a 10-year experience. Ann N Y Acad Sci 2007;1110:455-64. (Pubitemid 350043035)